{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:06:38Z","timestamp":1740146798225,"version":"3.37.3"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010270","name":"the Capital Health Research and Development of Special","doi-asserted-by":"crossref","award":["2020-2-4026"],"award-info":[{"award-number":["2020-2-4026"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873283"],"award-info":[{"award-number":["81873283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82104958"],"award-info":[{"award-number":["82104958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005149","name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2020-JKCS-001"],"award-info":[{"award-number":["2020-JKCS-001"]}],"id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005149","name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2019XK320072"],"award-info":[{"award-number":["2019XK320072"]}],"id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Lung cancer has the highest mortality rate of about 18.0% among malignant tumors worldwide, and chemotherapy is the main treatment. 80% of patients receiving chemotherapy suffers from cancer-related fatigue, which is the most severe symptom, with a large effect on quality of life as well as prognosis. Oral Chinese medicine, a kind of complementary and alternative medicine, has been proved to benefit lung cancer patients. However, no studies have reviewed whether it can reduce fatigue in lung cancer patients after chemotherapy, which is the purpose of our study.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Two reviewers will systematically and independently retrieve papers, select studies for inclusion, extract data, and assess risk of bias. The following nine databases will be searched: China National Knowledge Infrastructure, Wan Fang database, Chinese Scientific Journals Database, Chinese biomedical literature service system, PubMed, Web of Science, OVID, Scopus, and EMBASE from inception to February, 2022. Included studies will only be randomized controlled trials. Primary outcome is cancer-related fatigue. Secondary outcomes are quality of life, immunologic function, and the incidence of adverse events. We will use RoB 2 tool to assess the risk of bias and RevMan to analyze data. Risk ratios will be calculated for dichotomous data and mean differences for continuous data. Random-effect model will be used to integrate statistical effects. Meta-regression, subgroup and sensitivity analyses will be carried out. We will evaluate the strength and overall quality of evidence with four levels: very low, low, moderate, and high.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The review of current evidence of oral Chinese medicine on cancer-related fatigue for lung cancer patients after chemotherapy will be narratively summarized and quantitatively analyzed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The definitive conclusion will help physicians to determine whether oral Chinese medicine is an effective treatment for reducing fatigue in lung cancer patients after chemotherapy in clinical settings.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Systematic review registration<\/jats:title>\n<jats:p>PROSPERO CRD42021292576.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0270203","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T17:34:00Z","timestamp":1656610440000},"page":"e0270203","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of oral Chinese medicine on cancer-related fatigue for lung cancer patients after chemotherapy: Protocol for systematic review and meta-analysis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-4152","authenticated-orcid":true,"given":"Peijin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"issue":"3","key":"pone.0270203.ref001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA: a cancer journal for clinicians"},{"issue":"7","key":"pone.0270203.ref002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"W Cao","year":"2021","journal-title":"Chinese medical journal"},{"issue":"7","key":"pone.0270203.ref003","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdz131","article-title":"Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001","volume":"30","author":"AT Shaw","year":"2019","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"7","key":"pone.0270203.ref004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.18.00149","article-title":"Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50","volume":"37","author":"M Reck","year":"2019","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"pone.0270203.ref005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","article-title":"Cancer-Related Fatigue: Causes and Current Treatment Options","volume":"21","author":"MSY Thong","year":"2020","journal-title":"Current treatment options in oncology"},{"issue":"6","key":"pone.0270203.ref006","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.mcna.2017.06.007","article-title":"Cancer-Related Fatigue in Cancer Survivorship","volume":"101","author":"CC Ebede","year":"2017","journal-title":"The Medical clinics of North America"},{"issue":"4","key":"pone.0270203.ref007","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.21671","article-title":"Fatigue in long-term breast carcinoma survivors: a longitudinal investigation","volume":"106","author":"JE Bower","year":"2006","journal-title":"Cancer"},{"issue":"9384","key":"pone.0270203.ref008","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(03)14186-4","article-title":"Assessment and management of cancer-related fatigue in adults","volume":"362","author":"K Ahlberg","year":"2003","journal-title":"Lancet (London, England)"},{"issue":"Suppl 1","key":"pone.0270203.ref009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.12-S1-4","article-title":"Cancer-related fatigue: the scale of the problem","volume":"12","author":"M Hofman","year":"2007","journal-title":"The oncologist"},{"issue":"7","key":"pone.0270203.ref010","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3390\/cells8070738","article-title":"A Narrative Review of Cancer-Related Fatigue (CRF) and Its Possible Pathogenesis","volume":"8","author":"S Yang","year":"2019","journal-title":"Cells"},{"key":"pone.0270203.ref011","doi-asserted-by":"crossref","first-page":"658792","DOI":"10.3389\/fphar.2021.658792","article-title":"Platinum Accumulation and Cancer-Related Fatigue, Correlation With IL-8, TNF-\u03b1 and Hemocytes","volume":"12","author":"Y Zhang","year":"2021","journal-title":"Frontiers in pharmacology"},{"issue":"6","key":"pone.0270203.ref012","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","article-title":"Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment","volume":"31","author":"A Fabi","year":"2020","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"10","key":"pone.0270203.ref013","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bjsports-2016-096422","article-title":"Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis","volume":"52","author":"R Hilfiker","year":"2018","journal-title":"British journal of sports medicine"},{"issue":"12","key":"pone.0270203.ref014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11912-021-01135-6","article-title":"Cancer-Related Fatigue-Is There a Role for Complementary and Integrative Medicine?","volume":"23","author":"A David","year":"2021","journal-title":"Current oncology reports"},{"issue":"1","key":"pone.0270203.ref015","first-page":"CD010802","article-title":"Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer","volume":"1","author":"H Cramer","year":"2017","journal-title":"The Cochrane database of systematic reviews"},{"issue":"2","key":"pone.0270203.ref016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00520-017-3955-6","article-title":"Effects of acupuncture on cancer-related fatigue: a meta-analysis","volume":"26","author":"Y Zhang","year":"2018","journal-title":"Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"5","key":"pone.0270203.ref017","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1142\/S0192415X18500490","article-title":"Chinese Herbal Medicine for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis","volume":"46","author":"XW Zhang","year":"2018","journal-title":"The American journal of Chinese medicine"},{"key":"pone.0270203.ref018","doi-asserted-by":"crossref","first-page":"111381","DOI":"10.1016\/j.biopha.2021.111381","article-title":"Traditional Chinese medicine and lung cancer\u2013From theory to practice","volume":"137","author":"Z Li","year":"2021","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"3","key":"pone.0270203.ref019","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ctim.2014.04.007","article-title":"Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials","volume":"22","author":"CX Su","year":"2014","journal-title":"Complementary therapies in medicine"},{"key":"pone.0270203.ref020","doi-asserted-by":"crossref","first-page":"2456873","DOI":"10.1155\/2020\/2456873","article-title":"Effect of Traditional Chinese Medicine Injection on Cancer-Related Fatigue: A Meta-Analysis Based on Existing Evidence","volume":"2020","author":"Z Huang","year":"2020","journal-title":"Evidence-based complementary and alternative medicine: eCAM"},{"key":"pone.0270203.ref021","unstructured":"Higgins JPT CJCMLTPMWVe Thomas J. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022);. http:\/\/www.training.cochrane.org\/handbook."},{"issue":"1","key":"pone.0270203.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Systematic reviews"},{"issue":"3","key":"pone.0270203.ref023","first-page":"190","article-title":"Screening, evaluation, and management of cancer-related fatigue: Ready for implementation to practice?","volume":"65","author":"AM Berger","year":"2015","journal-title":"CA: a cancer journal for clinicians"},{"issue":"3","key":"pone.0270203.ref024","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"DF Cella","year":"1993","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"pone.0270203.ref025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"NK Aaronson","year":"1993","journal-title":"Journal of the National Cancer Institute"},{"key":"pone.0270203.ref026","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ (Clinical research ed)"},{"issue":"7650","key":"pone.0270203.ref027","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"pone.0270203.ref028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5603\/ARM.2017.0013","article-title":"The assessment of cancer-related fatigue syndrome in patients with lung cancer during palliative chemotherapy","volume":"85","author":"A Nowicki","year":"2017","journal-title":"Advances in respiratory medicine"},{"key":"pone.0270203.ref029","doi-asserted-by":"crossref","first-page":"105187","DOI":"10.1016\/j.phrs.2020.105187","article-title":"Current Policies and Measures on the Development of Traditional Chinese Medicine in China","volume":"163","author":"WY Wang","year":"2021","journal-title":"Pharmacological research"},{"issue":"12","key":"pone.0270203.ref030","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00432-017-2491-6","article-title":"Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients","volume":"143","author":"YH Liao","year":"2017","journal-title":"Journal of cancer research and clinical oncology"},{"key":"pone.0270203.ref031","doi-asserted-by":"crossref","first-page":"112836","DOI":"10.1016\/j.jep.2020.112836","article-title":"Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p","volume":"258","author":"Z Jiang","year":"2020","journal-title":"Journal of ethnopharmacology"},{"issue":"8","key":"pone.0270203.ref032","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s00520-020-05433-w","article-title":"Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials","volume":"28","author":"J Yang","year":"2020","journal-title":"Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"5","key":"pone.0270203.ref033","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpainsymman.2019.10.018","article-title":"A Phase II Randomized Controlled Trial of Renshen Yangrong Tang Herbal Extract Granules for Fatigue Reduction in Cancer Survivors","volume":"59","author":"Y Xu","year":"2020","journal-title":"Journal of pain and symptom management"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T17:34:33Z","timestamp":1656610473000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270203"}},"subtitle":[],"editor":[{"given":"Ning","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0270203","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}